Palmetto Pharmaceuticals' Series C Round

Palmetto Pharmaceuticals raised a round of funding on April 17, 2003.

Palmetto Pharmaceuticals (formerly eNOS Pharmaceuticals) has developed products that improve and restore blood flow and to reduce triglycerides through up-regulation of endothelial nitric oxide syntha…

Articles about Palmetto Pharmaceuticals' Series C Round: